In conclusion, our study elucidated that the landscape of BRG expression profiles in RA synovium and preliminarily explored the diagnostic value and biological functions of hub BRDEGs, namely, FAS, GPR183, and TFRC, which may be potential targets for clinical diagnosis and immunoregulatory therapy of RA. This evidence concerns the gene FAS and rheumatoid arthritis.